Dr Claudine Kraan
Dr Claudine Kraan
Details
Role
Research Officer
Research area
The Centre for Community Child Health
Group
Prevention Innovation
Dr Kraan (BBNSc (Hons), PhD) is a cognitive neuroscientist with expertise in genetic neurodevelopmental disorders. Held appointments are in GenV, Prevention Innovation, Murdoch Children’s Research Institute (MCRI), the Australian Institute of Health Innovation, Macquarie University, and University of Melbourne (Honorary Level C). She has a PhD in Advanced Behavioural Neuroscience from the School of Psychology, Monash University and a recently completed a NHMRC fellowship in Genomic Medicine at MCRI.
As of 2024, Dr Kraan is undertaking two new roles. (1) GenV School Entry Wave project overseeing selection of the wearable technology and digital neurodevelopment phenotyping approaches. (2) Genomics in Primary care project via Centre for Healthcare Resilience and Implementation Science (CHRIS), Macquarie University / seconded to Genomics in Society, MCRI. She also holds positions as Vice chair of the Fragile X Association of Australia (FXAA) Scientific, Clinical and Research Committee (since Feb 2023) and Founder and Chair of Annual Fragile X Roundtable.
As of 2024, Dr Kraan is undertaking two new roles. (1) GenV School Entry Wave project overseeing selection of the wearable technology and digital neurodevelopment phenotyping approaches. (2) Genomics in Primary care project via Centre for Healthcare Resilience and Implementation Science (CHRIS), Macquarie University / seconded to Genomics in Society, MCRI. She also holds positions as Vice chair of the Fragile X Association of Australia (FXAA) Scientific, Clinical and Research Committee (since Feb 2023) and Founder and Chair of Annual Fragile X Roundtable.
Dr Kraan (BBNSc (Hons), PhD) is a cognitive neuroscientist with expertise in genetic neurodevelopmental disorders. Held appointments are in GenV, Prevention Innovation, Murdoch Children’s Research Institute (MCRI), the Australian Institute of Health...
Dr Kraan (BBNSc (Hons), PhD) is a cognitive neuroscientist with expertise in genetic neurodevelopmental disorders. Held appointments are in GenV, Prevention Innovation, Murdoch Children’s Research Institute (MCRI), the Australian Institute of Health Innovation, Macquarie University, and University of Melbourne (Honorary Level C). She has a PhD in Advanced Behavioural Neuroscience from the School of Psychology, Monash University and a recently completed a NHMRC fellowship in Genomic Medicine at MCRI.
As of 2024, Dr Kraan is undertaking two new roles. (1) GenV School Entry Wave project overseeing selection of the wearable technology and digital neurodevelopment phenotyping approaches. (2) Genomics in Primary care project via Centre for Healthcare Resilience and Implementation Science (CHRIS), Macquarie University / seconded to Genomics in Society, MCRI. She also holds positions as Vice chair of the Fragile X Association of Australia (FXAA) Scientific, Clinical and Research Committee (since Feb 2023) and Founder and Chair of Annual Fragile X Roundtable.
As of 2024, Dr Kraan is undertaking two new roles. (1) GenV School Entry Wave project overseeing selection of the wearable technology and digital neurodevelopment phenotyping approaches. (2) Genomics in Primary care project via Centre for Healthcare Resilience and Implementation Science (CHRIS), Macquarie University / seconded to Genomics in Society, MCRI. She also holds positions as Vice chair of the Fragile X Association of Australia (FXAA) Scientific, Clinical and Research Committee (since Feb 2023) and Founder and Chair of Annual Fragile X Roundtable.
Top Publications
- Baker, EK, Arpone, M, Bui, M, Kraan, CM, Ling, L, Francis, D, Hunter, MF, Rogers, C, Field, MJ, Santa María, L, et al. Tissue mosaicism, FMR1 expression and intellectual functioning in males with fragile X syndrome.. Am J Med Genet A 191(2) : 357 -369 2023 view publication
- Kraan, CM, Date, P, Rattray, A, Sangeux, M, Bui, QM, Baker, EK, Morison, J, Amor, DJ, Godler, DE. Feasibility of wearable technology for 'real-world' gait analysis in children with Prader-Willi and Angelman syndromes.. J Intellect Disabil Res 66(8-9) : 717 -725 2022 view publication
- Martin, EM, Zhu, Y, Kraan, CM, Kumar, KR, Godler, DE, Field, M. Men with FMR1 premutation alleles of less than 71 CGG repeats have low risk of being affected with fragile X-associated tremor/ataxia syndrome (FXTAS).. J Med Genet 59(7) : 706 -709 2022 view publication
- Carroll, K, Kennedy, RA, Koutoulas, V, Bui, M, Kraan, CM. Validation of shoe-worn Gait Up Physilog®5 wearable inertial sensors in adolescents.. Gait Posture 91: 19 -25 2022 view publication
- Kraan, CM, Baker, EK, Arpone, M, Bui, M, Ling, L, Gamage, D, Bretherton, L, Rogers, C, Field, MJ, Wotton, TL, et al. DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome.. Int J Mol Sci 21(20) : 2020 view publication
Page 1 of 10
Career information
Share //
